Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 80/100

Failure Rate

28.6%

2 terminated/withdrawn out of 7 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

29%

2 trials in Phase 3/4

Results Transparency

25%

1 of 4 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A

3(50.0%)

Phase 3

2(33.3%)

Phase 2

1(16.7%)

6Total

N/A(3)

Phase 3(2)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT03247439Not ApplicableUnknown

Safety and Effectiveness of Cartiva Implant in the Treatment of First CMC Joint Osteoarthritis Compared to LRTI (GRIP 2)

Role: lead

NCT02978573Phase 3Completed

Post Approval Study to Evaluate the Effectiveness and Safety of Cartiva Implant in the Treatment of OA of the Great Toe

Role: lead

NCT02391506Not ApplicableCompleted

Safety and Effectiveness of Cartiva Implant in the Treatment of First CMC Joint Osteoarthritis

Role: lead

NCT00642382Not ApplicableTerminated

Safety and Effectiveness of Agilus (Hyaluronic Acid) for Ankle Osteoarthritis

Role: lead

NCT02452671Terminated

Observational Plan to Obtain Clinical Experience and Follow up Data on the Use of the ProxiFuse Hammer Toe Device

Role: lead

NCT00969969Phase 3Completed

A Study to Evaluate the Effectiveness and Safety of an Implant in the Treatment of Osteoarthritis of the Great Toe

Role: lead

NCT02066844Phase 2Completed

Navigator vs Standard Needle Injection for Hip

Role: lead

All 7 trials loaded